Anteris Technologies Global Corp. — Capital/Financing Update 2018

Jun 3, 2018

4.06.18

==> picture [452 x 24] intentionally omitted <==

ASX ANNOUNCEMENT

ASX Market Announcements Australian Securities Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

RESULTS OF SHARE PURCHASE PLAN

Admedus Limited (ASX:AHZ) (the Company ) is pleased to announce that the Company’s share purchase plan (the SPP ) has closed, with 9,203,573 shares subscribed for at $0.30, raising $2.76 million.

The Company wishes to thank all shareholders that participated in the SPP for their continued support which will help to facilitate further expansion and acceleration of its new product pipeline, including TAVR and the unique 3D shaped tissue portfolio.

Allotment of shares will occur today, with an expected quotation date and trading of shares on 5 June 2018.

ENDS

About Admedus Limited

Admedus (ASX:AHZ) is a medical technologies company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Our focus is on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow product and service offerings and expanding revenues from our existing medical sales and distribution business. The company has assets from research & development through clinical development as well as sales, marketing and distribution.

Website: www.admedus.com

Facebook: www.facebook.com/Admedus Twitter: @Admedus

For more information, please contact

Admedus Limited

Barbara Ferres

+61 7 3152 3216

communications@admedus.com

Admedus Limited

ABN 35 088 221 078

Registered Office Level 9 301 Coronation Drive Milton QLD 4064

Customer Service T 1300 550 310 F 1300 880 398 International T: +61 8 9266 0100 F: +61 8 9266 0199

E: info@admedus.com W: www.admedus.com

Brisbane • Minneapolis Zurich • Singapore